Brief: Composition Of Matter Patent For Qn-302 Granted By United States Patent And Trademark Office

Aixcrypto Holdings

21/03/2023 12:36

March 21 (Reuters) - Qualigen Therapeutics Inc  QLGN.O :
    * COMPOSITION OF MATTER PATENT FOR QN-302 GRANTED BY UNITED
STATES
PATENT AND TRADEMARK OFFICE
    * QUALIGEN THERAPEUTICS INC - HAS RECEIVED NOTICE OF INTENT
FROM
EUROPEAN PATENT OFFICE TO GRANT SIMILAR PATENT IN E.U.
    * QUALIGEN THERAPEUTICS INC - PATENT PROTECTS COMPOSITION OF
MATTER FOR QN-302 AND BACK-UP COMPOUNDS, WITH EXCLUSIVITY TO
COMPANY INTO 2040

Source text for Eikon:  ID:nGNX2HpgJ3 
Further company coverage:  QLGN.O 

 ((Reuters.Briefs@thomsonreuters.com;;))